<!DOCTYPE  html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>rgpv syllabus MPharm PCI Grading System 2nd SemesterMicrosoft Word - M Pharm PCI Syllabus all branches</title><meta name="author" content="HP"/><style type="text/css"> * {margin:0; padding:0; text-indent:0; }
 .s1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 10pt; }
 .s2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 .p, p { color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; margin:0pt; }
 .s3 { color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; vertical-align: 1pt; }
 .s4 { color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 6pt; }
 .s5 { color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 6pt; vertical-align: 2pt; }
 li {display: block; }
 #l1 {padding-left: 0pt;counter-reset: c1 2; }
 #l1> li>*:first-child:before {counter-increment: c1; content: counter(c1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l1> li:first-child>*:first-child:before {counter-increment: c1 0;  }
 #l2 {padding-left: 0pt;counter-reset: c2 1; }
 #l2> li>*:first-child:before {counter-increment: c2; content: counter(c2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l2> li:first-child>*:first-child:before {counter-increment: c2 0;  }
 li {display: block; }
 #l3 {padding-left: 0pt;counter-reset: d1 2; }
 #l3> li>*:first-child:before {counter-increment: d1; content: counter(d1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l3> li:first-child>*:first-child:before {counter-increment: d1 0;  }
 #l4 {padding-left: 0pt;counter-reset: d2 1; }
 #l4> li>*:first-child:before {counter-increment: d2; content: counter(d2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l4> li:first-child>*:first-child:before {counter-increment: d2 0;  }
 li {display: block; }
 #l5 {padding-left: 0pt;counter-reset: e1 2; }
 #l5> li>*:first-child:before {counter-increment: e1; content: counter(e1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l5> li:first-child>*:first-child:before {counter-increment: e1 0;  }
 li {display: block; }
 #l6 {padding-left: 0pt;counter-reset: f1 1; }
 #l6> li>*:first-child:before {counter-increment: f1; content: counter(f1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l6> li:first-child>*:first-child:before {counter-increment: f1 0;  }
 li {display: block; }
 #l7 {padding-left: 0pt;counter-reset: g1 2; }
 #l7> li>*:first-child:before {counter-increment: g1; content: counter(g1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l7> li:first-child>*:first-child:before {counter-increment: g1 0;  }
 #l8 {padding-left: 0pt;counter-reset: g2 1; }
 #l8> li>*:first-child:before {counter-increment: g2; content: counter(g2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l8> li:first-child>*:first-child:before {counter-increment: g2 0;  }
 li {display: block; }
 #l9 {padding-left: 0pt;counter-reset: h1 1; }
 #l9> li>*:first-child:before {counter-increment: h1; content: counter(h1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l9> li:first-child>*:first-child:before {counter-increment: h1 0;  }
 li {display: block; }
 #l10 {padding-left: 0pt;counter-reset: i1 20; }
 #l10> li>*:first-child:before {counter-increment: i1; content: counter(i1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 #l10> li:first-child>*:first-child:before {counter-increment: i1 0;  }
</style><!-- Basic Meta Tags -->
<meta charset="utf-8" />
<meta http-equiv="X-UA-Compatible" content="IE=edge" />
<meta name="viewport" content="width=device-width,initial-scale=1" />

<!-- Page Title and Description -->
<meta name="description" content="Download and view the latest RGPV syllabus and timetable in PDF." />
<meta name="keywords" content="download, view, RGPV, syllabus, timetable, PDF" />

<!-- Robots Meta Tag -->
<meta name="robots" content="index, follow" />
<link rel="sitemap" href="/sitemap.xml" />

<!-- Twitter Meta Tags -->
<meta name="twitter:card" content="summary_large_image" />
<meta name="twitter:title" content="RGPV Syllabus and Timetable" />
<meta name="twitter:description" content="Download and view the latest RGPV syllabus and timetable in PDF." />

<!-- Open Graph Meta Tags -->
<meta property="og:locale" content="en_IN" />
<meta property="og:type" content="website" />
<meta property="og:site_name" content="RGPV Syllabus and Timetable" />
<meta property="og:title" content="RGPV Syllabus and Timetable" />
<meta property="og:description" content="Download and view the latest RGPV syllabus and timetable in PDF." />

<!-- Other Tags -->
<link rel="prefetch" />
<meta name="audience" content="all" />
<meta name="rating" content="general" />
<meta name="generator" content="site" />
<meta name="google" content="translate" />
<meta name="theme-color" content="#4DBA87" />
<meta name="geo.placename" content="India" />
<meta name="revisit-after" content="1 days" />
<meta property="fb:admins" content="100012765211323" />
<meta name="apple-mobile-web-app-capable" content="no" />

<!-- Apple Touch Icon -->
<meta name="apple-mobile-web-app-title" content="www.rgpv-syllabus-timetable.in" />
<meta name="apple-mobile-web-app-status-bar-style" content="default" />
<link rel="apple-touch-icon" href="/img/icons/apple-touch-icon-152x152.png" />

<!-- Favicon and Icons -->
<link rel="mask-icon" href="/img/icons/safari-pinned-tab.svg" color="#4DBA87" />
<link rel="icon" type="image/png" sizes="32x32" href="/img/icons/favicon-32x32.png" />
<link rel="icon" type="image/png" sizes="16x16" href="/img/icons/favicon-16x16.png" />
<meta name="msapplication-TileImage" content="/img/icons/msapplication-icon-144x144.png" />

<!-- Search Engine Tags -->
<meta name="search engines" content="Aeiwi, Alexa, AllTheWeb, AltaVista, AOL Netfind, Anzwers, Canada, DirectHit, EuroSeek, Excite, Overture, Go, Google, HotBot, InfoMak, Kanoodle, Lycos, MasterSite, National Directory, Northern Light, SearchIt, SimpleSearch, WebsMostLinked, WebTop, What-U-Seek, AOL, Yahoo, WebCrawler, Infoseek, Excite, Magellan, LookSmart, CNET, Googlebot" />

<!-- Pingback and OpenID -->
<link rel="pingback" href="https://www.rgpv-syllabus-timetable.in/" />
<link rel="openid.delegate" href="https://www.rgpv-syllabus-timetable.in/" />

<!-- Content Type -->
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
<body><div style="display:flex;justify-content:flex-end;"><a href="#" target="_blank" download="" id="pdf-download-link"><button type="button" style="cursor:pointer;-webkit-appearance:button;color:#fff;background-color:#007bff;border-color:#007bff;display:inline-block;font-weight:400;text-align:center;white-space:nowrap;vertical-align:middle;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;border:1px solid transparent;padding:0.375rem 0.75rem;font-size:1rem;line-height:1.5;border-radius:0.25rem;transition:color .15s ease-in-out,background-color .15s ease-in-out,border-color .15s ease-in-out,box-shadow .15s ease-in-out;text-transform:none;overflow:visible;margin:0;font-family:inherit;" download>Download PDF</button></a></div><script>const a=(window.location.pathname).split("/");const filename="" + a[a.length-1] + ".pdf";document.getElementById("pdf-download-link").href=filename;</script><p class="s1" style="padding-top: 3pt;padding-left: 33pt;text-indent: 0pt;line-height: 113%;text-align: center;">MOLECULAR PHARMACEUTICS (NANO TECHNOLOGY &amp; TARGETED DDS) (NTDS)</p><p class="s1" style="padding-left: 33pt;text-indent: 0pt;text-align: center;">(MPH 201T)</p><p class="s2" style="padding-top: 1pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 4pt;padding-left: 5pt;text-indent: 0pt;line-height: 75%;text-align: left;">This course is designed to impart knowledge on the area of advances in novel drug delivery systems.</p><p class="s2" style="padding-top: 5pt;padding-left: 11pt;text-indent: 0pt;line-height: 10pt;text-align: left;">Objectives</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Upon completion of the course student shall be able to understand</p><p class="s2" style="padding-top: 1pt;padding-left: 41pt;text-indent: -18pt;line-height: 78%;text-align: left;">ï‚·  <span class="p">The various approaches for development of novel drug delivery systems.</span></p><p class="s2" style="padding-left: 41pt;text-indent: -18pt;line-height: 78%;text-align: left;">ï‚·  <span class="p">The criteria for selection of drugs and polymers for the development of NTDS</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">ï‚·  <span class="p">The formulation and evaluation of novel drug delivery systems.</span></p><p class="s2" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                                60 Hrs</p><p style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 87%;text-align: justify;">1. <span class="s2">Targeted Drug  Delivery Systems:  C</span>oncepts, Events and biological process involved in drug targeting. Tumor targeting and Brain specific delivery.</p><ol id="l1"><li data-list-text="2"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 9pt;text-align: justify;">Targeting Methods<span class="p">: introduction preparation and evaluation.</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">Nano Particles &amp; Liposomes: Types, preparation and evaluation.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="3"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Micro Capsules / Micro Spheres: <span class="p">Types, preparation and evaluation , Monoclonal Antibodies ; preparation and application, preparation and application of Niosomes, Aquasomes, Phytosomes, Electrosomes.</span></p></li><li data-list-text="4"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 10pt;text-align: justify;">Pulmonary Drug Delivery Systems <span class="p">: Aerosols, propellents,</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">ContainersTypes, preparation and evaluation, Intra Nasal Route Delivery systems; Types, preparation and evaluation.</p></li><li data-list-text="5"><p style="padding-top: 2pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Nucleic acid based therapeutic delivery system : Gene therapy, introduction (ex-vivo &amp; in-vivo gene therapy). Potential target diseases for gene therapy (inherited disorder and cancer). Gene expression systems (viral and nonviral gene transfer). Liposomal gene delivery systems.</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Biodistribution and Pharmacokinetics. knowledge of therapeutic antisense molecules and aptamers as drugs of future.</p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;line-height: 7pt;text-align: left;">REFERENCES</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><ol id="l2"><li data-list-text="1."><p style="padding-top: 4pt;padding-left: 26pt;text-indent: -14pt;line-height: 76%;text-align: left;">Y W. Chien, Novel Drug Delivery Systems, 2nd edition, revised and expanded,Marcel Dekker, Inc., New York, 1992.</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 75%;text-align: left;">S.P.Vyas and R.K.Khar, Controlled Drug Delivery - concepts and advances, VallabhPrakashan, New Delhi, First edition 2002.</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 75%;text-align: left;">N.K. Jain, Controlled and Novel Drug Delivery, CBS Publishers &amp; Distributors, NewDelhi, First edition 1997 (reprint in 2001).</p></li></ol></li></ol><p class="s1" style="padding-top: 3pt;padding-left: 138pt;text-indent: -114pt;line-height: 112%;text-align: left;">ADVANCED BIOPHARMACEUTICS &amp; PHARMACOKINETICS (MPH 202T)</p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">This course is designed to impart knowledge and skills necessary for dose calculations, dose adjustments and to apply biopharmaceutics theories in practical problem solving. Basic theoretical discussions of the principles of biopharmaceutics and pharmacokinetics are provided to help the studentsâ€™ to clarify the concepts.</p><p class="s2" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 89%;text-align: justify;">Upon completion of this course it is expected that students will be able understand,</p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">ï‚·  <span class="p">The basic concepts in biopharmaceutics and pharmacokinetics.</span></p><p class="s2" style="padding-top: 1pt;padding-left: 41pt;text-indent: -18pt;line-height: 86%;text-align: justify;">ï‚· <span class="p">The use raw data and derive the pharmacokinetic models and parameters the best describe the process of drug absorption, distribution, metabolism and elimination.</span></p><p class="s2" style="padding-left: 41pt;text-indent: -18pt;line-height: 89%;text-align: justify;">ï‚· <span class="p">The critical evaluation of biopharmaceutic studies involving drug product equivalency.</span></p><p class="s2" style="padding-left: 41pt;text-indent: -18pt;line-height: 88%;text-align: justify;">ï‚· <span class="p">The design and evaluation of dosage regimens of the drugs using pharmacokinetic and biopharmaceutic parameters.</span></p><p class="s2" style="padding-left: 41pt;text-indent: -18pt;line-height: 90%;text-align: justify;">ï‚· <span class="p">The potential clinical pharmacokinetic problems and application of basics of pharmacokinetic</span></p><p class="s2" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                                 60 Hrs</p><p style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">1.  <span class="s2">Drug  Absorption  from  the  Gastrointestinal  Tract</span>: Gastrointestinal tract, Mechanism of drug absorption, Factors affecting drug absorption, pHâ€“partition theory of drug absorption. Formuulation and physicochemical factors: Dissolution rate, Dissolution process, Noyesâ€“Whitney equation and drug dissolution, Factors affecting the dissolution rate. Gastrointestinal absorption: role of the dosage form: Solution (elixir, syrup and solution) as a dosage form ,Suspension as a dosage form, Capsule as a dosage form, Tablet as a dosage form ,Dissolution methods ,Formulation and processing factors, Correlation of in vivo data with in vitro dissolution data.Transport model: Permeability-Solubility-Charge State and the pH Partition Hypothesis, Properties of the Gastrointestinal Tract (GIT), pH Microclimate  Intracellular  pH  Environment,  Tight-Junction Complex.</p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><ol id="l3"><li data-list-text="2"><p class="s2" style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Biopharmaceutic  considerations  in  drug  product  design and  In  Vitro  Drug  Product  Performance:  <span class="p">Introduction, biopharmaceutic factors affecting drug bioavailability, rate-limiting steps in drug absorption, physicochemical nature of the drug formulation factors affecting drug product performance, </span>in vitro<span class="p">: dissolution and drug release testing, compendial methods of dissolution, alternative methods of dissolution testing,meeting dissolution requirements,problems of variable control in dissolution testingperformance of drug products. </span>In vitro<span class="p">â€“</span>in vivo <span class="p">correlation, dissolution  profile  comparisons,    drug  product stability,considerations in the design of a drug product.</span></p></li><li data-list-text="3"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;"><span class="s2">Pharmacokinetics:  </span><span class="p">Basic  considerations,  pharmacokinetic models, compartment modeling: one compartment model- IV bolus, IV infusion, extra-vascular. Multi compartment model:two compartment - model in brief, non-linear pharmacokinetics: cause </span>of non-linearity, Michaelis â€“ Menten equation, estimation of k<span class="s4">max </span>and v<span class="s4">max</span>. Drug interactions: introduction, the effect of protein- <span class="p">binding  interactions,the  effect  of  tissue-binding interactions,cytochrome p450-based drug interactions,drug interactions linked to transporters.</span></p></li><li data-list-text="4"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 9pt;text-align: left;">Drug Product Performance, In  Vivo:  Bioavailability  and</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Bioequivalence<span class="p">: drug product performance, purpose of bioavailability studies, relative and absolute availability. methods for assessing bioavailability, bioequivalence studies, design and evaluation of bioequivalence studies, study designs, crossover study designs, evaluation of the data, bioequivalence example, study submission and drug review process. biopharmaceutics classification system, methods. Permeability: In-vitro, in-situ and In-vivo  methods.generic  biologics  (biosimilar  drug products),clinical significance of bioequivalence studies, special concerns in bioavailability and bioequivalence studies, generic substitution.</span></p></li><li data-list-text="5"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Application of  Pharmacokinetics:  <span class="p">Modified-Release  Drug Products, Targeted Drug Delivery Systems and Biotechnological Products.  Introduction  to  Pharmacokinetics  and pharmacodynamic, drug interactions. Pharmacokinetics and pharmacodynamics of biotechnology drugs. Introduction, Proteins and peptides, Monoclonal antibodies, Oligonucleotides, Vaccines (immunotherapy), Gene therapies.</span></p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p class="s2" style="padding-top: 3pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l4"><li data-list-text="1."><p style="padding-top: 3pt;padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: justify;">Biopharmaceutics and Clinical Pharmacokinetics by Milo Gibaldi, 4th edition,Philadelphia, Lea and Febiger, 1991</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Biopharmaceutics and Pharmacokinetics, A. Treatise, D .M. Brahmankar and Sunil B. Jaiswal., VallabPrakashan, Pitampura, Delhi</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 83%;text-align: justify;">Applied Biopharmaceutics and Pharmacokinetics by Shargel. Land YuABC, 2<span class="s5">nd</span>edition, Connecticut Appleton Century Crofts, 1985</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: justify;">Textbook of Biopharmaceutics and Pharmacokinetics, Dr. Shobha Rani R. Hiremath,Prism Book</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Pharmacokinetics by Milo Gibaldi and D. Perrier, 2nd edition, Marcel Dekker Inc.,New York, 1982</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: justify;">Current Concepts in Pharmaceutical Sciences: Biopharmaceutics, Swarbrick. J, Leaand Febiger, Philadelphia, 1970</p></li><li data-list-text="7."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Clinical Pharmacokinetics, Concepts and Applications 3rd edition by MalcolmRowland and Thom~ N. Tozer, Lea and Febiger, Philadelphia, 1995</p></li><li data-list-text="8."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Dissolution, Bioavailability and Bioequivalence, Abdou. H.M, Mack PublishingCompany, Pennsylvania 1989</p></li><li data-list-text="9."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Biopharmaceutics and Clinical Pharmacokinetics, An Introduction, 4th edition,revised and expande by Robert. E. Notari, Marcel Dekker Inc, New York and Basel,1987.</p></li><li data-list-text="10."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: justify;">Biopharmaceutics and Relevant Pharmacokinetics by John. G Wagner and M.Pemarowski, 1st edition, Drug Intelligence Publications, Hamilton, Illinois, 1971.</p></li><li data-list-text="11."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Encyclopedia of Pharmaceutical Technology, Vol 13, James Swarbrick, James. G.Boylan, Marcel Dekker Inc, New York, 1996.</p></li><li data-list-text="12."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Basic Pharmacokinetics,1 st edition,Sunil S JambhekarandPhilip J Breen,pharmaceutical press, RPS Publishing,2009.</p></li><li data-list-text="13."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 84%;text-align: justify;">Absorption and Drug Development- Solubility, Permeability, and Charge State, Alex Avdeef, John Wiley &amp; Sons, Inc,2003.</p></li></ol></li></ol><p class="s1" style="padding-top: 3pt;padding-left: 138pt;text-indent: -73pt;line-height: 113%;text-align: left;">COMPUTER AIDED DRUG DEVELOPMENT (MPH 203T)</p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">This course is designed to impart knowledge and skills necessary for computer Applications in pharmaceutical research and development who want to understand the application of computers across the entire drug research and development process. Basic theoretical discussions of the principles of more integrated and coherent use of computerized information (informatics) in the drug development process are provided to help the students to clarify the concepts.</p><p class="s2" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: left;">Upon completion of this course it is expected that students will be able to understand,</p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">ï‚·  <span class="p">History of Computers in Pharmaceutical Research and Development</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">ï‚·  <span class="p">Computational Modeling of Drug Disposition</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">ï‚·  <span class="p">Computers in Preclinical Development</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">ï‚·  <span class="p">Optimization Techniques in Pharmaceutical Formulation</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">ï‚·  <span class="p">Computers in Market Analysis</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">ï‚·  <span class="p">Computers in Clinical Development</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">ï‚·  <span class="p">Artificial Intelligence (AI) and Robotics</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">ï‚·  <span class="p">Computational fluid dynamics(CFD)</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                                60 Hrs</p><p style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">1.  a. <span class="s2">Computers   in   Pharmaceutical   Research   and Development</span>: A General Overview: History of Computers in Pharmaceutical Research and Development. Statistical modeling in Pharmaceutical research and development: Descriptive versus Mechanistic Modeling, Statistical Parameters, Estimation, Confidence Regions, Nonlinearity at the Optimum, Sensitivity Analysis, Optimal Design, Population Modeling</p><p style="padding-left: 26pt;text-indent: 0pt;line-height: 9pt;text-align: left;">b. <span class="s2">Quality-by-Design  In  Pharmaceutical  Development:</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 89%;text-align: justify;">Introduction, ICH Q8 guideline, Regulatory and industry views on QbD, Scientifically based QbD - examples of application.</p><ol id="l5"><li data-list-text="2"><p style="padding-left: 27pt;text-indent: -22pt;line-height: 11pt;text-align: justify;">Computational Modeling Of Drug Disposition: Introduction</p><p style="padding-top: 1pt;padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">,Modeling Techniques: Drug Absorption, Solubility, Intestinal Permeation, Drug Distribution ,Drug Excretion, Active Transport; P-gp, BCRP, Nucleoside Transporters, hPEPT1, ASBT, OCT, OATP, BBB-Choline Transporter.</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p></li><li data-list-text="3"><p class="s2" style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Computer-aided  formulation  development<span class="p">:</span>:  <span class="p">Concept  of optimization, Optimization parameters, Factorial design, Optimization technology &amp; Screening design. Computers in Pharmaceutical Formulation: Development of pharmaceutical emulsions, microemulsion drug carriers Legal Protection of Innovative Uses of Computers in R&amp;D, The Ethics of Computing in Pharmaceutical Research, Computers in Market analysis</span></p></li><li data-list-text="4"><p style="padding-left: 33pt;text-indent: -28pt;line-height: 86%;text-align: justify;">a.  <span class="s2">Computer-aided   biopharmaceutical   characterization</span>: Gastrointestinal absorption simulation. Introduction, Theoretical background, Model construction, Parameter sensitivity analysis, Virtual trial, Fed vs. fasted state, In vitro dissolution and <span class="s2">in vitro- in vivo </span>correlation, Biowaiver considerations</p><p style="text-indent: 0pt;line-height: 9pt;text-align: right;">b. <span class="s2">Computer  Simulations  in  Pharmacokinetics  and</span></p><p class="s2" style="padding-left: 34pt;text-indent: 0pt;line-height: 86%;text-align: left;">Pharmacodynamics: <span class="p">Introduction, Computer Simulation: Whole Organism, Isolated Tissues, Organs, Cell, Proteins and Genes.</span></p><p style="padding-left: 33pt;text-indent: -3pt;line-height: 87%;text-align: left;">c. <span class="s2">Computers in Clinical Development</span>: Clinical Data Collection and Management, Regulation of Computer Systems</p></li><li data-list-text="5"><p class="s2" style="padding-left: 22pt;text-indent: -22pt;line-height: 10pt;text-align: right;">Artificial Intelligence (AI), Robotics and  Computational  fluid</p></li></ol><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">dynamics: <span class="p">General overview, Pharmaceutical Automation, Pharmaceutical applications, Advantages and Disadvantages. Current Challenges and Future Directions.</span></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l6"><li data-list-text="1."><p style="padding-top: 3pt;padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Computer Applications in Pharmaceutical Research and Development, Sean Ekins, 2006, John Wiley &amp; Sons.</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 10pt;text-align: left;">Computer-Aided Applications in Pharmaceutical Technology, 1<span class="s5">st </span>Edition,</p><p style="padding-left: 26pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Jelena Djuris, Woodhead Publishing</p></li><li data-list-text="3."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 84%;text-align: left;">Encyclopedia of Pharmaceutical Technology, Vol 13, James Swarbrick, James. G.Boylan, Marcel Dekker Inc, New York, 1996.</p></li></ol><p class="s1" style="padding-top: 3pt;padding-left: 138pt;text-indent: -63pt;line-height: 113%;text-align: left;">COSMETICS AND COSMECEUTICALS (MPH 204T)</p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: left;">This course is designed to impart knowledge and skills necessary forthefundamental need for cosmetic and cosmeceutical products.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Upon completion of the course, the students shall be able to understand</p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">ï‚·  <span class="p">Key ingredients used in cosmetics and cosmeceuticals.</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">ï‚·  <span class="p">Key building blocks for various formulations.</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">ï‚·  <span class="p">Current technologies in the market</span></p><p class="s2" style="padding-top: 1pt;padding-left: 41pt;text-indent: -18pt;line-height: 89%;text-align: left;">ï‚·  <span class="p">Various key ingredients and basic science to develop cosmetics and cosmeceuticals</span></p><p class="s2" style="padding-left: 41pt;text-indent: -18pt;line-height: 88%;text-align: left;">ï‚·  <span class="p">Scientific knowledge to develop cosmetics and cosmeceuticals with desired Safety, stability, and efficacy.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                                 60 Hrs</p><p style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">1. <span class="s2">Cosmetics â€“ Regulatory : </span>Definition of cosmetic products as per Indian regulation. Indian regulatory requirements for labeling of cosmetics Regulatory provisions relating to import of cosmetics., Misbranded and spurious cosmetics. Regulatory provisions relating to manufacture of cosmetics â€“ Conditions for obtaining license, prohibition of manufacture and sale of certain cosmetics, loan license, offences and penalties.</p><ol id="l7"><li data-list-text="2"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: left;">Cosmetics - Biological aspects : <span class="p">Structure of skin relating to problems like dry skin, acne, pigmentation, prickly heat, wrinkles and body odor. Structure of hair and hair growth cycle. Common problems associated with oral cavity. Cleansing and care needs for face, eye lids, lips, hands, feet, nail, scalp, neck, body and under-arm.</span></p></li><li data-list-text="3"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Formulation Building blocks: <span class="p">Building blocks for different product formulations of cosmetics/cosmeceuticals. Surfactants â€“ Classification and application. Emollients, rheological additives: classification and application. Antimicrobial used as preservatives, their merits and demerits. Factors affecting microbial preservative efficacy. Building blocks for formulation of a moisturizing cream, vanishing cream, cold cream, shampoo and toothpaste. Soaps and syndetbars.</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 9pt;text-align: justify;">Perfumes<span class="p">; Classification of perfumes. Perfume ingredients listed</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">as allergens in EU regulation.</p><p style="padding-top: 2pt;padding-left: 3pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 3pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 3pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 3pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 3pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 3pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p class="s2" style="padding-top: 3pt;padding-left: 27pt;text-indent: 0pt;line-height: 89%;text-align: justify;">Controversial ingredients: <span class="p">Parabens, formaldehyde liberators, dioxane.</span></p></li><li data-list-text="4"><p class="s2" style="padding-top: 1pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Design of cosmeceutical products: <span class="p">Sun protection, sunscreens classification and regulatory aspects. Addressing dry skin, acne, sun-protection, pigmentation, prickly heat, wrinkles, body odor., dandruff, dental cavities, bleeding gums, mouth odor and sensitive teeth through cosmeceutical formulations.</span></p></li><li data-list-text="5"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 84%;text-align: left;">Herbal Cosmetics : <span class="p">Herbal ingredients used in Hair care, skin care and oral care. Review of guidelines for herbal cosmetics by private bodies like cosmos with respect to preservatives, emollients, foaming agents, emulsifiers and rheology modifiers. Challenges in formulating herbal cosmetics.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l8"><li data-list-text="1."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 13pt;text-align: left;">Harryâ€™s Cosmeticology. 8<span class="s5">th </span>edition.</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 13pt;text-align: left;">Poucherâ€™sperfumecosmeticsandSoaps,10<span class="s5">th </span>edition.</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 89%;text-align: left;">Cosmetics - Formulation, Manufacture and quality control, PP.Sharma,4<span class="s5">th </span>edition</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 10pt;text-align: left;">Handbook of cosmetic science and Technology A.O.Barel, M.Paye and</p><p style="padding-left: 26pt;text-indent: 0pt;line-height: 12pt;text-align: left;">H.I. Maibach. 3 <span class="s5">rd </span>edition</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Cosmetic and Toiletries recent suppliers catalogue.</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 13pt;text-align: left;">CTFA directory.</p></li></ol></li></ol><p class="s1" style="padding-top: 3pt;padding-left: 141pt;text-indent: -56pt;line-height: 113%;text-align: left;">PHARMACEUTICS PRACTICALS - II (MPH 205P)</p><ol id="l9"><li data-list-text="1."><p style="padding-top: 4pt;padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">To study the effect of temperature change , non solvent addition, incompatible polymer addition in microcapsules preparation</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 9pt;text-align: left;">Preparation and evaluation of Alginate beads</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Formulation and evaluation of gelatin /albumin microspheres</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Formulation and evaluation of liposomes/niosomes</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 13pt;text-align: left;">Formulation and evaluation of spherules</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Improvement of dissolution characteristics of slightly soluble drug by Solid dispersion technique.</p></li><li data-list-text="7."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: left;">Comparison of dissolution of two different marketed products /brands</p></li><li data-list-text="8."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: left;">Protein binding studies of a highly protein bound drug &amp; poorly protein bound drug</p></li><li data-list-text="9."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 10pt;text-align: left;">Bioavailability studies of Paracetamol in animals.</p></li><li data-list-text="10."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Pharmacokinetic and IVIVC data analysis by Winnoline<span class="s5">R </span>software</p></li><li data-list-text="11."><p class="s2" style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">In vitro <span class="p">cell studies for permeability and metabolism</span></p></li><li data-list-text="12."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">DoE Using Design Expert<span class="s5">Â® </span>Software</p></li><li data-list-text="13."><p style="padding-left: 12pt;text-indent: 0pt;line-height: 87%;text-align: left;">Formulation data analysis Using Design Expert<span class="s5">Â® </span>Software 14.Quality-by-Design in Pharmaceutical Development</p></li></ol><p style="padding-left: 12pt;text-indent: 0pt;line-height: 86%;text-align: left;">15.Computer Simulations in Pharmacokinetics and Pharmacodynamics 16.Computational Modeling Of Drug Disposition</p><p style="padding-left: 12pt;text-indent: 0pt;line-height: 11pt;text-align: left;">17.To develop Clinical Data Collection manual</p><p style="padding-left: 12pt;text-indent: 0pt;line-height: 88%;text-align: left;">18.To carry out Sensitivity Analysis, and Population Modeling. 19.Development and evaluation of Creams</p><ol id="l10"><li data-list-text="20."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: left;">Development and evaluation of Shampoo and Toothpaste base</p></li><li data-list-text="21."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 13pt;text-align: left;">To incorporate herbal and chemical actives to develop products</p></li><li data-list-text="22."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 82%;text-align: left;">To address Dry skin, acne, blemish, Wrinkles, bleeding gums and dandruff</p></li></ol></body></html>
